Yes, agree always good to get another persons point of view but his disclaimer states that he makes no representation to his blogs accuracy. That's a relief, because he totally confused the 250 patient CPN 10 RA Phase 11b subcut trial in 2011, with the 23 patient intravenous trial back in 2005. Likewise, there has been no demonstratable link between CPN10 and cancer, more research needs to be done.
I have read a few other blogs of his, and his treatment of Invion is mild by comparison.
INVO2 can Repair Damaged LUNGS, page-20
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.41M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 9849314 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 6055724 | 26 |
View Market Depth
| Last trade - 10.42am 11/07/2024 (20 minute delay) ? |
| IVX (ASX) Chart |
Day chart unavailable